Jonathan Hirsch brings a technical healthcare background to Rebel Fund, having worked hands-on in clinical genomics and oncology data at Paradigm Health, including building molecular tumor boards and targeted-therapy workflows inside real hospital systems like Intermountain. He now focuses on making clinical trials run more smoothly in everyday care settings, writing about site capacity, research policy, and global trends in countries like China and Japan.